SWX:NOVOB - Novo Nordisk A/S Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close€47.79
Today's RangeN/A
52-Week Range€33.43 - €56.35
VolumeN/A
Average Volume671 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive NOVOB News and Ratings via Email

Sign-up to receive the latest news and ratings for NOVOB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange SWX
Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolSWX:NOVOB
Previous Symbol
CUSIPN/A
WebN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable

Novo Nordisk A/S (SWX:NOVOB) Frequently Asked Questions

What is Novo Nordisk A/S's stock symbol?

Novo Nordisk A/S trades on the SWX under the ticker symbol "NOVOB."

What is the consensus analysts' recommendation for Novo Nordisk A/S?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Novo Nordisk A/S in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Novo Nordisk A/S.

Has Novo Nordisk A/S been receiving favorable news coverage?

News coverage about NOVOB stock has trended somewhat positive this week, InfoTrie reports. The research firm rates the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Novo Nordisk A/S earned a media sentiment score of 1.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.


MarketBeat Community Rating for Novo Nordisk A/S (SWX NOVOB)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  48 (Vote Outperform)
Underperform Votes:  60 (Vote Underperform)
Total Votes:  108
MarketBeat's community ratings are surveys of what our community members think about Novo Nordisk A/S and other stocks. Vote "Outperform" if you believe NOVOB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NOVOB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2018 by MarketBeat.com Staff

Featured Article: Bond

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel